When intuition falters: repeated testing accuracy during an epidemic.
COVID-19
Lateral flow test
Mass testing
Rapid antigen test
SARS-CoV-2
Surveillance testing
Journal
European journal of epidemiology
ISSN: 1573-7284
Titre abrégé: Eur J Epidemiol
Pays: Netherlands
ID NLM: 8508062
Informations de publication
Date de publication:
Jul 2021
Jul 2021
Historique:
received:
14
04
2021
accepted:
22
06
2021
pubmed:
30
7
2021
medline:
3
9
2021
entrez:
29
7
2021
Statut:
ppublish
Résumé
Widespread, repeated testing using rapid antigen tests to proactively detect asymptomatic SARS-CoV-2 infections has been a promising yet controversial topic during the COVID-19 pandemic. Concerns have been raised over whether currently authorized lateral flow tests are sufficiently sensitive and specific to detect enough infections to impact transmission whilst minimizing unnecessary isolation of false positives. These concerns have often been illustrated using simple, textbook calculations of positivity rates and positive predictive value assuming fixed values for sensitivity, specificity and prevalence. However, we argue that evaluating repeated testing strategies requires the consideration of three additional factors: new infections continue to arise depending on the incidence rate, isolating positive individuals reduces prevalence in the tested population, and each infected individual is tested multiple times during their infection course. We provide a simple mathematical model with an online interface to illustrate how these three factors impact test positivity rates and the number of isolating individuals over time. These results highlight the potential pitfalls of using inappropriate textbook-style calculations to evaluate statistics arising from repeated testing strategies during an epidemic.
Identifiants
pubmed: 34322830
doi: 10.1007/s10654-021-00786-w
pii: 10.1007/s10654-021-00786-w
pmc: PMC8318052
doi:
Types de publication
Letter
Langues
eng
Sous-ensembles de citation
IM
Pagination
749-752Subventions
Organisme : NIH HHS
ID : DP5 OD028145
Pays : United States
Organisme : Wellcome Trust
ID : 210758/Z/18/Z
Pays : United Kingdom
Organisme : NIH Office of the Director
ID : DP5-OD028145
Organisme : NIGMS NIH HHS
ID : U54 GM088558
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : NIGMS NIH HHS
ID : U54GM088558
Pays : United States
Informations de copyright
© 2021. The Author(s).
Références
N Engl J Med. 1999 Jul 8;341(2):131
pubmed: 10409035
N Engl J Med. 2020 Nov 26;383(22):e120
pubmed: 32997903
BMJ. 2021 Mar 19;372:n706
pubmed: 33741566
Cochrane Database Syst Rev. 2021 Mar 24;3:CD013705
pubmed: 33760236